Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zeng, Gaofeng
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.	Recruiting	3	1600	RoW	rhNRG-1, Neucardin™, Placebo	Zensun Sci. & Tech. Co., Ltd.	Chronic Heart Failure	02/26	02/26
Hong, Yunfei
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.	Recruiting	3	1600	RoW	rhNRG-1, Neucardin™, Placebo	Zensun Sci. & Tech. Co., Ltd.	Chronic Heart Failure	02/26	02/26
Cao, Youliang
NCT05352516 / 2022-002188-31: A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture	Completed	3	514	RoW	HLX14, Prolia®	Shanghai Henlius Biotech, Shanghai Henlius Biotech, Inc.	Postmenopausal	12/23	07/24